Plain-English translation of NCT05637879 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our PTSD research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Researchers have noticed that , a medication normally used to treat hepatitis C, seemed to help people with PTSD symptoms. This trial is testing whether this medication — called — can actually reduce PTSD symptoms in people who don't have hepatitis C. About 92 veterans will receive either the medication or a placebo (a pill with no active ingredients) to see if the treatment works.
Doctors have observed that some patients taking this medication for hepatitis C experienced improvements in their PTSD symptoms, even though the medication wasn't designed for that purpose. This trial exists to see whether the medication could be a new treatment option for people struggling with trauma-related stress disorder.
You likely qualify if…
You likely don't qualify if…
You will take three tablets once daily for 8 weeks — either the medication being tested or a placebo, and neither you nor the researchers will know which one you're getting. The trial will measure how your PTSD symptoms and daily functioning change over time, and the researchers will monitor you for any side effects or safety concerns. Your participation involves taking the pills consistently and likely completing check-ins or assessments throughout the 8-week period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States